Our partners
DISCOVER THE PEOPLE SHAPING THE MEDICINE OF TOMORROW
RED works with public institutions, industry partners and community organisations to develop its projects.
Support RED
Transforming the lives of people affected by the world’s most common inherited blood disorder is within our reach.
OUR PARTNERS
Public institutions
Foundations
Rare disease networks
Industry partners
Associations
Exemples of practical action
Advancing research into this inherited disorder
SCDiag is a rapid diagnostic test for sickle cell disease, developed with the support of UPEC and the University of Kinshasa.
Improving diagnosis and patient care
Siclopédie is a digital platform used to support the care of people with sickle cell disease. It is being developed with the MCGRE rare disease health network, with support from AFM-Téléthon and the French National Research Agency (ANR).
Raising awareness among the public and healthcare professionals
Webinars on sickle cell disease are organised with support from the MCGRE / Fil Rouge rare disease health network. RED also works with Radio France, franceinfo and Fondation Groupama on television and radio coverage.
Supporting affected families
The Drépagarde project provides childcare support with the help of CAF 93, Fondation Groupama and Pfizer.
Patient associations
RED also works with independent patient associations. They support and inform patients and families, and they bring practical experience to the network's projects.
Nous soutenir
pour leur offrir
un meilleur avenir
Chaque don finance directement des actions sur le terrain : équiper un centre de dépistage, former un médecin, développer un outil d'information pour les patients. La drépanocytose touche des millions de personnes, mais elle reste largement sous-financée. Votre soutien change concrètement des vies.
Nos projets
Nous menons des programmes concrets pour dépister plus tôt, soigner mieux et informer davantage. Nos projets couvrent la recherche, la prévention, l'éducation thérapeutique et l'accès aux soins dans les régions les plus touchées.